315 related articles for article (PubMed ID: 15567898)
21. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N;
J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885
[TBL] [Abstract][Full Text] [Related]
22. A longitudinal follow-up of hand involvement and activities of daily living in early systemic sclerosis.
Sandqvist G; Hesselstrand R; Eberhardt K
Scand J Rheumatol; 2009; 38(4):304-10. PubMed ID: 19296402
[TBL] [Abstract][Full Text] [Related]
23. Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody.
Sacks DG; Okano Y; Steen VD; Curtiss E; Shapiro LS; Medsger TA
J Rheumatol; 1996 Apr; 23(4):639-42. PubMed ID: 8730118
[TBL] [Abstract][Full Text] [Related]
24. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
Colakoğlu M; Cobankara V; Akpolat T
Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
[TBL] [Abstract][Full Text] [Related]
25. Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis.
Nihtyanova SI; Brough GM; Black CM; Denton CP
Ann Rheum Dis; 2008 Jan; 67(1):120-3. PubMed ID: 17660220
[TBL] [Abstract][Full Text] [Related]
26. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
Walker UA; Tyndall A; Czirják L; Denton C; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Bocelli-Tyndall C; Matucci-Cerinic M
Ann Rheum Dis; 2007 Jun; 66(6):754-63. PubMed ID: 17234652
[TBL] [Abstract][Full Text] [Related]
27. The Relationship between Smoking, Raynaud's Phenomenon, Digital Ulcers, and Skin Thickness in the Waikato Systemic Sclerosis Cohort.
Silva C; Solanki KK; White DHN
Rheumatol Immunol Res; 2022 Jun; 3(2):84-89. PubMed ID: 36465326
[TBL] [Abstract][Full Text] [Related]
28. The relationship between nailfold capillaroscopic assessment and telangiectasia score with severity of peripheral vascular involvement in systemic sclerosis.
Yalcinkaya Y; Pehlivan O; Omma A; Alpay N; Erer B; Kamali S; Ocal L; Inanc M
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S92-7. PubMed ID: 25797836
[TBL] [Abstract][Full Text] [Related]
29. [Antiendothelial antibodies in systemic scleroderma and Raynaud's disease].
Salozhin KV; Shcherbakov AB; Nasonov EL; Kolesova NV; Romanov IuA; Guseva NG
Ter Arkh; 1995; 67(5):54-7. PubMed ID: 7638782
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of serum levels of matrix metalloproteinase-13 in patients with systemic sclerosis.
Asano Y; Ihn H; Kubo M; Jinnin M; Mimura Y; Ashida R; Tamaki K
Rheumatology (Oxford); 2006 Mar; 45(3):303-7. PubMed ID: 16278285
[TBL] [Abstract][Full Text] [Related]
31. Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis.
Sulli A; Soldano S; Pizzorni C; Montagna P; Secchi ME; Villaggio B; Seriolo B; Brizzolara R; Cutolo M
J Rheumatol; 2009 Jun; 36(6):1235-9. PubMed ID: 19369451
[TBL] [Abstract][Full Text] [Related]
32. Digital iontophoresis of vasoactive substances as measured by laser Doppler imaging--a non-invasive technique by which to measure microvascular dysfunction in Raynaud's phenomenon.
Anderson ME; Moore TL; Lunt M; Herrick AL
Rheumatology (Oxford); 2004 Aug; 43(8):986-91. PubMed ID: 15199217
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database.
Frantz C; Huscher D; Avouac J; Hachulla E; Balbir-Gurman A; Riemekasten G; Siegert E; Lazzaroni MG; Carreira PE; Vettori S; Zanatta E; Ullman S; Czirjàk L; Kowal-Bielecka O; Distler O; Matucci-Cerinic M; Allanore Y;
Autoimmun Rev; 2020 Feb; 19(2):102452. PubMed ID: 31838157
[TBL] [Abstract][Full Text] [Related]
34. Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study.
Nihtyanova SI; Tang EC; Coghlan JG; Wells AU; Black CM; Denton CP
QJM; 2010 Feb; 103(2):109-15. PubMed ID: 19966313
[TBL] [Abstract][Full Text] [Related]
35. Differences Sustained Between Diffuse and Limited Forms of Juvenile Systemic Sclerosis in an Expanded International Cohort.
Foeldvari I; Klotsche J; Kasapcopur O; Adrovic A; Terreri MT; Sakamoto AP; Stanevicha V; Sztajnbok F; Anton J; Feldman B; Alexeeva E; Katsicas M; Smith V; Avcin T; Marrani E; Kostik M; Lehman T; Sifuentes-Giraldo WA; Vasquez-Canizares N; Appenzeller S; Janarthanan M; Moll M; Nemcova D; Patwardhan A; Santos MJ; Sawhney S; Schonenberg-Meinema D; Battagliotti C; Berntson L; Bica B; Brunner J; Costa-Reis P; Eleftheriou D; Harel L; Horneff G; Kaiser D; Kallinich T; Lazarevic D; Minden K; Nielsen S; Nuruzzaman F; Uziel Y; Helmus N; Torok KS
Arthritis Care Res (Hoboken); 2022 Oct; 74(10):1575-1584. PubMed ID: 33787070
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of serum retinol binding protein-4 levels in patients with systemic sclerosis.
Toyama T; Asano Y; Takahashi T; Aozasa N; Akamata K; Noda S; Taniguchi T; Ichimura Y; Sumida H; Tamaki Z; Masui Y; Tada Y; Sugaya M; Sato S; Kadono T
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):337-44. PubMed ID: 22211766
[TBL] [Abstract][Full Text] [Related]
37. The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis.
Davies CA; Jeziorska M; Freemont AJ; Herrick AL
Hum Pathol; 2006 Feb; 37(2):190-7. PubMed ID: 16426919
[TBL] [Abstract][Full Text] [Related]
38. Serum adiponectin levels inversely correlate with the activity of progressive skin sclerosis in patients with diffuse cutaneous systemic sclerosis.
Masui Y; Asano Y; Shibata S; Noda S; Aozasa N; Akamata K; Yamada D; Tamaki Z; Tada Y; Sugaya M; Sato S; Kadono T
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):354-60. PubMed ID: 21504484
[TBL] [Abstract][Full Text] [Related]
39. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
Simon D; Czömpöly T; Berki T; Minier T; Peti A; Tóth E; Czirják L; Németh P
Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
[TBL] [Abstract][Full Text] [Related]
40. Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register.
Hanitsch LG; Burmester GR; Witt C; Hunzelmann N; Genth E; Krieg T; Lehmacher W; Melchers I; Meurer M; Müller-Ladner U; Schulze-Lohoff E; Becker M; Sunderkoetter C; ; Riemekasten G
Rheumatology (Oxford); 2009 Jan; 48(1):70-3. PubMed ID: 19056798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
